Assay ID | Title | Year | Journal | Article |
AID765377 | Inhibition of recombinant human HDAC5 enzyme using Ac-LeuGlyLys (tfa)-AMC as substrate at 50 uM after 15 to 30 mins | 2013 | Journal of medicinal chemistry, Aug-22, Volume: 56, Issue:16
| Total synthesis and full histone deacetylase inhibitory profiling of Azumamides A-E as well as β²- epi-Azumamide E and β³-epi-Azumamide E. |
AID765392 | Inhibition of recombinant human HDAC2 enzyme using flurogenic Ac-LeuGlyLys (Ac)-AMC as substrate after 15 to 30 mins | 2013 | Journal of medicinal chemistry, Aug-22, Volume: 56, Issue:16
| Total synthesis and full histone deacetylase inhibitory profiling of Azumamides A-E as well as β²- epi-Azumamide E and β³-epi-Azumamide E. |
AID724345 | Inhibition of HDAC (unknown origin) | 2013 | European journal of medicinal chemistry, Feb, Volume: 60 | Linear and cyclic glycopeptide as HIV protease inhibitors. |
AID1170750 | Cytotoxic activity against human EB3 cells assessed as growth inhibition up to 25 uM after 3 days by MTT assay | 2014 | Journal of medicinal chemistry, Nov-26, Volume: 57, Issue:22
| Methyl effect in azumamides provides insight into histone deacetylase inhibition by macrocycles. |
AID331616 | Inhibition of human HDAC4 expressed in 293T cells | 2008 | Bioorganic & medicinal chemistry letters, May-01, Volume: 18, Issue:9
| Evaluation of antiangiogenic activity of azumamides by the in vitro vascular organization model using mouse induced pluripotent stem (iPS) cells. |
AID765391 | Inhibition of GST-tagged recombinant human HDAC3/NcoR1 enzyme using flurogenic Ac-LeuGlyLys (Ac)-AMC as substrate after 15 to 30 mins | 2013 | Journal of medicinal chemistry, Aug-22, Volume: 56, Issue:16
| Total synthesis and full histone deacetylase inhibitory profiling of Azumamides A-E as well as β²- epi-Azumamide E and β³-epi-Azumamide E. |
AID765393 | Inhibition of recombinant human HDAC1 enzyme using flurogenic Ac-LeuGlyLys (Ac)-AMC as substrate after 15 to 30 mins | 2013 | Journal of medicinal chemistry, Aug-22, Volume: 56, Issue:16
| Total synthesis and full histone deacetylase inhibitory profiling of Azumamides A-E as well as β²- epi-Azumamide E and β³-epi-Azumamide E. |
AID316931 | Inhibition of HDAC3 | 2008 | Journal of medicinal chemistry, Mar-27, Volume: 51, Issue:6
| Histone deacetylase inhibitors: from bench to clinic. |
AID331615 | Inhibition of human HDAC1 expressed in 293T cells | 2008 | Bioorganic & medicinal chemistry letters, May-01, Volume: 18, Issue:9
| Evaluation of antiangiogenic activity of azumamides by the in vitro vascular organization model using mouse induced pluripotent stem (iPS) cells. |
AID331618 | Induction of p21 expression in human HeLa cells after 24 hrs | 2008 | Bioorganic & medicinal chemistry letters, May-01, Volume: 18, Issue:9
| Evaluation of antiangiogenic activity of azumamides by the in vitro vascular organization model using mouse induced pluripotent stem (iPS) cells. |
AID765390 | Inhibition of recombinant human HDAC8 enzyme using Ac-LeuGlyLys (tfa)-AMC as substrate after 15 to 30 mins | 2013 | Journal of medicinal chemistry, Aug-22, Volume: 56, Issue:16
| Total synthesis and full histone deacetylase inhibitory profiling of Azumamides A-E as well as β²- epi-Azumamide E and β³-epi-Azumamide E. |
AID316936 | Inhibition of HDAC7 | 2008 | Journal of medicinal chemistry, Mar-27, Volume: 51, Issue:6
| Histone deacetylase inhibitors: from bench to clinic. |
AID765374 | Inhibition of recombinant human HDAC9 enzyme using Ac-LeuGlyLys (tfa)-AMC as substrate at 50 uM after 15 to 30 mins | 2013 | Journal of medicinal chemistry, Aug-22, Volume: 56, Issue:16
| Total synthesis and full histone deacetylase inhibitory profiling of Azumamides A-E as well as β²- epi-Azumamide E and β³-epi-Azumamide E. |
AID765376 | Inhibition of recombinant human HDAC7 enzyme using Ac-LeuGlyLys (tfa)-AMC as substrate at 50 uM after 15 to 30 mins | 2013 | Journal of medicinal chemistry, Aug-22, Volume: 56, Issue:16
| Total synthesis and full histone deacetylase inhibitory profiling of Azumamides A-E as well as β²- epi-Azumamide E and β³-epi-Azumamide E. |
AID316941 | Inhibition of HDAC9 | 2008 | Journal of medicinal chemistry, Mar-27, Volume: 51, Issue:6
| Histone deacetylase inhibitors: from bench to clinic. |
AID316893 | Inhibition of HDAC8 | 2008 | Journal of medicinal chemistry, Mar-27, Volume: 51, Issue:6
| Histone deacetylase inhibitors: from bench to clinic. |
AID316892 | Inhibition of HDAC1 | 2008 | Journal of medicinal chemistry, Mar-27, Volume: 51, Issue:6
| Histone deacetylase inhibitors: from bench to clinic. |
AID316898 | Inhibition of HDAC2 | 2008 | Journal of medicinal chemistry, Mar-27, Volume: 51, Issue:6
| Histone deacetylase inhibitors: from bench to clinic. |
AID316935 | Inhibition of HDAC5 | 2008 | Journal of medicinal chemistry, Mar-27, Volume: 51, Issue:6
| Histone deacetylase inhibitors: from bench to clinic. |
AID765383 | Inhibition of recombinant human HDAC11 enzyme using Ac-LeuGlyLys(Ac)-AMC as substrate after 15 to 30 mins | 2013 | Journal of medicinal chemistry, Aug-22, Volume: 56, Issue:16
| Total synthesis and full histone deacetylase inhibitory profiling of Azumamides A-E as well as β²- epi-Azumamide E and β³-epi-Azumamide E. |
AID765378 | Inhibition of recombinant human HDAC4 enzyme using Ac-LeuGlyLys (tfa)-AMC as substrate at 50 uM after 15 to 30 mins | 2013 | Journal of medicinal chemistry, Aug-22, Volume: 56, Issue:16
| Total synthesis and full histone deacetylase inhibitory profiling of Azumamides A-E as well as β²- epi-Azumamide E and β³-epi-Azumamide E. |
AID316899 | Inhibition of HDAC6 | 2008 | Journal of medicinal chemistry, Mar-27, Volume: 51, Issue:6
| Histone deacetylase inhibitors: from bench to clinic. |
AID331617 | Inhibition of human HDAC6 expressed in 293T cells | 2008 | Bioorganic & medicinal chemistry letters, May-01, Volume: 18, Issue:9
| Evaluation of antiangiogenic activity of azumamides by the in vitro vascular organization model using mouse induced pluripotent stem (iPS) cells. |
AID316951 | Inhibition of HDAC4 at 50 uM | 2008 | Journal of medicinal chemistry, Mar-27, Volume: 51, Issue:6
| Histone deacetylase inhibitors: from bench to clinic. |
AID765385 | Inhibition of recombinant human HDAC6 enzyme using flurogenic Ac-LeuGlyLys (Ac)-AMC as substrate after 15 to 30 mins | 2013 | Journal of medicinal chemistry, Aug-22, Volume: 56, Issue:16
| Total synthesis and full histone deacetylase inhibitory profiling of Azumamides A-E as well as β²- epi-Azumamide E and β³-epi-Azumamide E. |
AID765384 | Inhibition of recombinant human HDAC10 enzyme using tetrapeptide Ac-ArgThr-Lys(Ac)Lys(Ac)-AMC as substrate after 15 to 30 mins | 2013 | Journal of medicinal chemistry, Aug-22, Volume: 56, Issue:16
| Total synthesis and full histone deacetylase inhibitory profiling of Azumamides A-E as well as β²- epi-Azumamide E and β³-epi-Azumamide E. |
AID331619 | Antiangiogenic activity in mouse induced pluripotent stem cells | 2008 | Bioorganic & medicinal chemistry letters, May-01, Volume: 18, Issue:9
| Evaluation of antiangiogenic activity of azumamides by the in vitro vascular organization model using mouse induced pluripotent stem (iPS) cells. |
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |